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Abstract 
Background: Obesity contributes to left ventricular (LV) diastolic dysfunction (LVDD) and may lead to 
diastolic heart failure. Weight loss (WL) after bariatric surgery (BS) may influence LV morphology and 
function. Using echocardiography, this study assessed the effect of WL on LV diastolic function (LVDF) 
and LV and left atrium (LA) morphology 6 months after BS in young women with morbid obesity.
Methods: Echocardiography was performed in 60 women with body mass index ≥ 40 kg/m², aged 37.1 ±  
± 9.6 years prior to and 6 months after BS. In 38 patients, well-controlled arterial hypertension was 
present. Heart failure, coronary artery disease, atrial fibrillation and mitral stenosis were exclusion 
criteria. Parameters of LV and LA morphology were obtained. To evaluate LVDF, mitral peak early (E) 
and atrial (A) velocities, E-deceleration time (DcT), pulmonary vein S, D and A reversal velocities were 
measured. Peak early diastolic mitral annular velocities (E’) and E/E’ were assessed.
Results: Mean WL post BS was 35.7 kg (27%). A postoperative decrease in LV wall thickness, LV 
mass (mean 183.7 to 171.5 g, p = 0.001) and LA parameters (area, volume) were observed. LVDD was 
diagnosed in 3 patients prior to and in 2 of them subsequent to the procedure. An improvement in LVDF 
Doppler indices were noted: increased E/A, D and E’ lateral, and decreased S/D and lateral E/E’. None 
of the patients showed increased LV filling pressure. No significant correlations between hypertension 
and echo-parameters were demonstrated.
Conclusions: Six months after BS weight loss resulted in the improvement of LVDF and left heart 
morphology in morbidly obese women. (Cardiol J 2018; 25, 1: 97–105)
Key words: morbid obesity, bariatric surgery, echocardiography, left ventricular  
diastolic function, left atrium
Introduction
The role of obesity as an independent risk 
factor for the development of cardiovascular dis-
eases such as arterial hypertension, coronary 
artery disease and heart failure (HF) has been 
well documented in the literature [1]. The risk of 
developing HF increases by over 5% with every 
1 kg/m2 increase in the body mass index (BMI) [2]. 
Obesity predisposes to HF, mainly due to the im-
pairment of left ventricular (LV) relaxation caused 
by myocardial hypertrophy as well as due to an 
increase in circulating blood volume which influ-
ences preload and leads to higher stroke volume. 
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Left ventricular diastolic dysfunction (LVDD) is 
often found in obese patients, and obesity is one 
of the most common causes of HF with preserved 
ejection fraction [3, 4]. Bariatric surgery (BS) 
is associated with both reduced cardiovascular 
mortality and lower incidence of cardiovascular 
events in obese adults [5]. A new meta-analysis 
by Aggarwal et al. [6] supported the effects of BS 
on cardiac structure assessed by echocardiography 
and cardiac magnetic resonance, and suggested 
a significant improvement in cardiac morphology and 
function after bariatric procedures. There is still 
limited evidence with respect to an improvement 
in LV diastolic function (LVDF) in patients with se-
vere obesity after body mass (BM) reduction [4, 7].
The aim of this study was to assess the impact 
of BM reduction on LVDF and LV and left atrium (LA) 
morphology 6 months after BS with the use of echo-
cardiography in young women with morbid obesity.
Methods
Patients 
The study population consisted of patients 
qualified for BS in the referenced department and 
was characterized by high prevalence of women 
participants. Sixty women with class III obesity 
according to the World Health Organization (WHO) 
criteria, aged 37.1 ± 9.6 years, with BMI ≥ 40 kg/m2 
underwent cardiological evaluation followed by 
BS. Patients with coronary artery disease, atrial 
fibrillation, LV systolic dysfunction (left ventricu-
lar ejection fraction [LVEF] < 50%), HF or mitral 
stenosis, prosthetic mitral valves or surgical rings, 
significant aortic valve disease, chronic kidney 
disease and estimated glomerular filtration rate 
< 60 mL/min/1.73 m2, uncontrolled diabetes or 
systemic diseases were not included in the study. 
This study was approved by the Ethics Committee 
of the Medical University of Warsaw. All patients 
participating in the study gave written consent.
Clinical evaluation was performed at the time 
of qualification, in the majority of patients within 
1 month prior to surgery and 6 months after BS. 
The preoperative evaluation was performed when 
patients were in stable clinical condition and receiv-
ing optimal medical treatment. Anthropometric 
parameters such as BM, BMI, body surface area 
(BSA) and blood pressure (BP) along with the 
a list of currently used medications were recorded. 
Weight loss results were expressed in kilograms 
and relative measure — percentage excess weight 
loss (% EWL) and percent weight loss (% WL). At 
least 50% EWL was the criterium of successfully 
performed BS.
Bariatric surgery
Roux-en-Y gastric bypass was performed in 
24 patients and vertical banded gastroplasty in 
another 24 patients. Twelve patients underwent 
laparoscopic sleeve gastrectomy. The type of sur-
gery was chosen depending on patients’ BMI and 
co-morbidities. 
Echocardiography
Patients underwent transthoracic echocardio-
graphy with two-dimensional (2D), M-mode and 
Doppler assessments (iE33 Philips MS, Andover, 
MA). Despite the presence of severe obesity, 
echocardiographic image quality was adequate for 
the analysis in all patients. A standardized exami-
nation was performed with patients placed in the 
left-lateral decubitus position, with constant moni-
toring of a single electrocardiogram (ECG) lead. 
The findings were interpreted by an experienced 
physician according to the recommendations of the 
Echocardiography Working Group of the Polish 
Cardiac Society, based on the guidelines of the Eu-
ropean Association of Cardiovascular Imaging [8, 9]. 
A follow-up evaluation was performed 6 months 
after surgery and the sonographer was blinded to 
the results of the previous examination.
Left ventricle
Left ventricular end-diastolic diameter 
(LVEDd), interventricular septum (IVS) and pos-
terior (inferolateral) wall (PW) thickness were 
recorded at end-diastole using 2D and M-mode 
presentations in the parasternal long axis view. 
LV dimensions were recorded by placing the ultra-
sound beam maximally perpendicularly to its long 
axis. Measurements acquired in the M-mode were 
later verified using 2D visualizations. Wall thick-
ness ≥ 13 mm was defined as at least moderate LV 
hypertrophy (LVH), and severe hypertrophy when 
the wall thickness was ≥ 16 mm, respectively [9].
Left ventricular mass (LVM) was calculated 
using the following Devereux regression equation: 
LVM = {0.8 × 1.04 × [(IVS + LVEDd + PW)3 – 
LVEDd3] + 0.6} [10]. Adjusting LVM for BSA was 
performed to obtain the LV mass index (LVMI- 
-BSA). The upper limits for LVM and LVMI-BSA 
were 162 g and 95 g/m2, respectively. Moderate 
hypertrophy was defined as LVM ranging 187–210 
g and LVMI-BSA ranging 109–121 g/m2, whereas 
severe hypertrophy was defined as LVM > 210 g 
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and LVMI-BSA > 121 g/m2 [9]. LVMI was addition-
ally adjusted to height raised to the power of 2.7 
(LVMI-height) and defined LVH as the LVMI-height 
≥ 47 g/m2.7 [9, 11]. To evaluate LV geometry, LV 
relative wall thickness (RWT) using the following 
formula: RWT = 2 × PW/ LVEDd [9] was assessed.
The biplane method of disks summation 
(modified Simpson’s rule) to calculate LVEF was 
used [9]. 
Left ventricular diastolic function 
Left ventricular diastolic function was as-
sessed using Doppler mitral valve inflow (MVI) and 
pulmonary venous inflow (PVI) parameters, early 
diastolic mitral annular velocity in tissue Doppler 
imaging (TDI), and measurements of the LA [9, 12]. 
Using the sampling gate positioned in the mitral 
valve orifice, at the level of the leaflet tips, the MVI 
pattern was registered and the maximal velocity 
(Vmax) of the early wave (E) and the atrial wave 
(A) were measured. The E/A ratio was calculated 
followed by the measurement of the E-wave decel-
eration time (DcT) (Fig. 1A). After placing the Dop-
pler gate at the level of the right upper pulmonary 
vein, the spectrum of PVI was registered, Vmax of 
systolic (S) and diastolic (D) waves were measured, 
S/D ratio was calculated, which was followed by the 
measurement of Vmax of retrograde flow wave into 
pulmonary veins (Arev) during atrial contraction 
(Fig. 1B). Moreover, the duration of A (AD) and 
Arev (ArevD) were measured. Using TDI, the early 
diastolic velocities of the lateral (E’lat) and septal 
(E’ sept) parts of the mitral annulus were recorded 
(Fig. 2). The lateral, septal and average E/E’ ratios 
were then derived and the LV filling pressure (LVFP) 
was estimated. Doppler measurements reflected an 
average of 3 cardiac cycles. 
Left atrium morphology
Planimetry and volume measurements of the 
LA in 2D imaging were performed during late 
ventricular systole, immediately before mitral 
valve opening, when LA size is the largest. The 
maximal LA anterior-posterior dimension (LAd) 
was obtained in the long axis in the parasternal 
view — the upper limit for women was defined as 
38 mm. The LA was traced in the 4-chamber api-
cal view to calculate LA area (LAa) (Fig. 3). Mild 
enlargement was defined as LAa ≥ 20 cm2 [13].
The LA volume (LAV) was estimated using the 
modified Simpson’s method based on  disk summa-
tion acquired after tracing the outline of LA in two 
Figure 1. Mitral valve inflow; E — maximal velocity of the early wave; A — maximal velocity of the atrial wave; DcT — 
E-wave deceleration time (A). Pulmonary venous inflow. S — maximal velocity of the of systolic wave; D — maximal 
velocity of the diastolic wave; Arev — maximal velocity of the retrograde flow wave during atrial contraction (B).
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planes in 4- and 2-chamber apical views, excluding 
pulmonary vein orifices and LA appendage (Fig. 4). 
Mitral annulus was used as the lower LA border. 
The LA volume index (LAVI) was obtained by in-
dexing the LAV for BSA (mL/m2). Mildly abnormal 
values were considered when LAV ≥ 53 mL and 
LAVI ≥ 29 mL/m² and moderately abnormal when 
LAV ≥ 63 mL and LAVI ≥ 34 mL/m2 [9, 13].
Left ventricular diastolic dysfunction 
Left ventricular diastolic dysfunction was dia-
gnosed, when in TDI, E’lat < 10 cm/s or E’sept 
< 8 cm/s and at least two of the following were 
present: E/A < 0.8, DcT > 200 ms or predominant 
S wave during PVI (S/D > 1). An average E/E’ 
≤ 8 was defined as normal whereas E/E’ > 13 as 
increased LVFP, respectively. In cases with an 
Figure 2. Tissue Doppler imaging of lateral mitral annulus; E’ — early diastolic velocity.
Figure 3. Four chamber view: calculation of left atrial (LA) area.
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average E/E’ between 9 and 13, ArevD-AD ≥ 30 ms 
and LAVI ≥ 34 mL/m2 was additionally needed to 
diagnose increased LVFP [12].
Statistical analysis
Descriptive statistics for continuous variables 
are expressed as means and standard deviations 
or medians and range. Comparisons between 
measurements obtained before and after surgery 
for continuous variables were conducted with 
the use of dependent samples t-test or Wilcoxon 
signed-rank test, depending on the normality of 
the distribution of difference scores (assessed 
with the Shapiro-Wilk test). Comparisons between 
dichotomous variables were performed with the 
McNemar’s c2 test. All correlations were computed 
using the Spearman’s rho coefficient. Data were 
considered significant at p value < 0.05. 
Results
Group characteristics
Sixty women aged 37.1 ± 9.6 years, with class 
III obesity according to the WHO (median BMI 
47.0 kg/m2, IQR 12.5, mean BSA 2.1 ± 9.6 m2) 
were included in the study. Thirty-eight patients 
were diagnosed with arterial hypertension prior 
to the surgery (63.3%) (Table 1). These patients 
received standard treatment with angiotensin 
converting enzyme inhibitor (enalarpril), diuretics 
(furosemide) and in a few cases (6 patients) with 
beta-adrenolytics or calcium-blockers (bisoprolol or 
amlodipine). More than one antihypertensive drug 
was used by 23 patients. Nine (15.0%) patients had 
type 2 diabetes, which was treated with metformin 
in 8 cases and with insulin in 1 case.
Clinical evaluation
Six months after BS, the median WL was 
35.7 kg, with values ranging from 13.4 kg to 61.9 kg. 
The median %EWL was 48.8 (23.1–79.6) and the 
%WL was 27.0 (11.0–44.6). Representing weight 
changes as %EWL shows that BS was successful 
in a majority of cases — lower quartile of %EWL 
was equal to 44.
Arterial hypertension was found in 27 (45%) 
patients, the number of patients requiring more 
than one antihypertensive drug was reduced 
from 23 to 14. A normalization in BP values was 
achieved in 11 patients resulting in total discon-
tinuation of antihypertensive treatment. The num-
ber of patients with diabetes remained the same. 
After 6 months following BS, the BM, BSA 
and BMI (med. 34.0 kg/m2) of patients decreased 
significantly. The systolic and diastolic BP as well 
as the average heart rate values were significantly 
lower (Table 1).
The final effect of BS was related to BM and 
BMI prior to surgery. Women with the highest 
preoperative BM had the largest reduction in BM. 
A significant correlation between BM before BS and 
the difference score (Dbody mass) was observed 
Figure 4. Four chamber view: calculation of left atrial volume (LAV).
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(r = 0.61, p < 0.001). The same effect was noted 
for BMI values (r = 0.564, p < 0.001).
Echocardiographic assessment
Before BS, moderate hypertrophy of IVS 
(≥ 13 mm) was observed in 6 (10.0%) patients, and 
moderate hypertrophy of the PW in 5 (8.3%) cases. 
None of the studied patients were diagnosed with 
severe LVH (≥ 16 mm). Moderate LVH, defined 
as LVM 187–210 g, was present in 19 (31.7%) 
patients, and when defined as LVMI-BSA rang-
ing 109–121 g/m2, in 1 (1.7%) patient. Significant 
LVH (LVM ≥ 211 g) was observed in 11 women. 
None of the studied patients met the LVMI-BSA 
criteria for severe hypertrophy. After surgery, the 
LVEDd did not change significantly, however, the 
IVS and PW thickness were significantly reduced. 
Moderate hypertrophy of the IVS was observed 
in 2 (3.3%) women , and moderate hypertrophy of 
the PW in 1 (1.7%) patient. Hence, the LVM was 
also reduced. When analyzing the LVM, 12 patients 
met the criteria for moderate LVH and 6 patients 
were diagnosed with severe LVH. The LVMI-BSA 
was significantly higher after BS, because BM 
decreased faster than the LVM. The LVMI-height 
was significantly lower after BS and identified 
27 patients with LVH before and 18 patients after 
the procedure. There was no significant change 
in RWT when pre- and post-surgery values were 
compared (Table 2).
All patients studied had normal LV systolic 
function. LVEF was significantly higher after sur-
gery (Table 2).
Left ventricular diastolic  
function assessment
Prior to BS, mild LVDD (impaired LV relax-
ation) was diagnosed only in 3 patients based on 
MVI, PVI and TDI criteria. These 3 patients had 
hypertension, were older (48.3 ± 4.7 years) and 
had higher BMI (50.8 ± 9.1 kg/m2) than the remain-
ing patients.
Table 2. Left ventricle parameters before and 6 months after bariatric surgery (BS) (n = 60).
Parameter Before BS After BS P
LVEDd [mm] 46.3 ± 3.6 45.6 ± 3.6 0.167**
IVS [mm] 11.0 (9.0–14.0) 11.0 (9.0–13.0) 0.002*
PW [mm] 11.0 (9.0–14.0) 11.0 (9.0–13.0) 0.004*
LVM [g] 183.7 ± 32.2 171.5 ± 27.7 < 0.001**
LVMI-BSA [g/m2] 86.9 ± 14.3 92.1 ± 14.6 0.002**
LVMI-height [g/m2.7] 46.7 ± 9.0 43.6 ± 8.1 < 0.001**
RWT 0.476 ± 0.064 0.467 ± 0.048 0.231**
LVEF [%] 65 (55.0–68.0) 65 (60.0–68.0) 0.003*
*Wilcoxon signed-rank test; **Student’s t-test. Data are expressed as percentage, mean ± standard deviation or median and range; LVEDd — 
left ventricular end-diastolic diameter; IVS — interventricular septum thickness; PW — posterior (inferolateral) wall thickness; LVM — left  
ventricular mass; LVMI — left ventricular mass index adjusted for body surface area; LVMI-height — left ventricular mass index adjusted to 
height raised to the power of 2.7; RWT — relative wall thickness; LVEF — left ventricular ejection fraction
Table 1. Clinical characteristics of patients before and 6 months after bariatric surgery (BS) (n = 60).
Parameter Before BS After BS P
Hypertension 38 (63.3%) 27 (45.0%) 0.003
Body mass [kg] 129.1 (102.4–186.2) 94.75 (65.8–136.4) < 0.001*
BMI [kg/m2] 47.0 (39.45–64.25) 34.0 (26.4–50.7) < 0.001*
BSA [m2] 2.1 (1.8–2.5) 1.85 (1.5–2.2) < 0.001*
SBP [mm Hg] 130.0 (110.0–170.0) 120.0 (95.0–160.0) < 0.001*
DBP [mm Hg] 80.0 (70.0–90.0) 80.0 (60.0–85.0) < 0.001*
HR [bpm] 79.9 ± 9.35 72.3 ± 7.7 < 0.001**
*Wilcoxon signed-rank test; **Student’s t-test. Data are expressed as percentage, mean ± standard deviation or median and range; BMI — body 
mass index, BSA — body surface area; SBP — systolic blood pressure; DBP — diastolic blood pressure; HR — heart rate
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After surgery, 2 of them still met predefined 
LVDD criteria. On both examinations, no patients 
met criteria of significantly increased LVFP.
In the study group, the mean E/A ratio was 
significantly higher on follow-up examination when 
compared with the initial one. No significant dif-
ferences with respect to DcT were observed. 
However, the value of PVI diastolic velocity (D) 
was notably higher after surgery, the S/D ratio 
was significantly lower than that before surgery, 
and no differences for the S and Arev were noted 
(Table 3).
TDI evaluation revealed higher E’lat values 
on follow-up, while the E/E’lat was significantly 
lower than prior to BS (12.45 ± 2.9 vs. 15.7 ± 
± 3.6 cm/s, p = 0.09 and 7.5 ± 2.1 vs. 6.6 ± 2.1, 
p = 0.007, respectively). A comparison between 
the septal E’ and E/E’ showed no significant dif-
ferences (Table 3). 
Left atrium assessment
Prior to surgery, an enlargement of LAd > 38 
mm was observed in 10 (16.7%) women, and LAa 
≥ 20 cm2 was found in 9 (11.7%) women. Increased 
values were found of LAV in 9 females (15%; LAV 
≥ 63 mL in 4 patients, LAV ≥ 53 mL in 5 patients) and 
increased values of LAVI in 2 patients (3.3%; LAVI 
≥ 34 mL/m2 as well as LAVI ≥ 29 mL/m2 in 1 female).
After surgery, LAd and LAa exceeded the 
normal range in 4 (6.7%) women. Four (6.7%) pa-
tients had increased LAV values (LAV ≥ 63 mL in 
2 patients, LAV ≥ 53 mL in 2 patients). The number 
of women with increased LAVI was 5 (8.3%), and 
it was higher than before BS (LAVI ≥ 29 mL/m2 in 
2 patients, LAVI ≥ 34 mL/m2 in 3 patients) due to 
significant WL and decreased BSA.
The values of LAd, LAa and LAV were signifi-
cantly lower after BS. This trend was not observed 
for LAVI (Table 4).
Table 3. Doppler parameters of left ventricular diastolic function before and 6 months after bariatric 
surgery (BS) (n = 60).
Parameter Before BS After BS P
MVI E/A 1.1 (0.5–1.7) 1.2 (0.7–2.0) 0.04*
MVI DcT [MS] 192.5 ± 33.4 184.65 ± 29.35 0.194**
PVI S [m/s] 0.6 (0.4–0.9) 0.6 (0.3–1.0) 0.265*
PVI D [m/s] 0.4 (0.3–0.65) 0.45 (0.3–0.9) 0.007*
PVI S/D 1.42 ± 0.27 1.29 ± 0.33 0.003**
PVI Arev [m/s] 0.3 (0.2–0.4) 0.3  (0.2–0.4) 0.289*
E’ lateral [cm/s] 12.45 ± 2.9 15.7 ± 3.6 0.094**
E/E’ lateral 7.5 ± 2.1 6.6 ± 2.1 0.007**
E’ septal [cm/s] 10.3 (6.2–16.6) 11.5 (6.4–17.8) 0.489*
E/E’ septal 8.75 (5.8–12.7) 8.35 (5.3–11.5) 0.911*
*Wilcoxon signed-rank test; **Student’s t-test. Data are expressed as mean ± standard deviation or median and range; MVI/PVI — mitral/ 
/pulmonary vein inflow; E — mitral peak early diastolic velocity; A — mitral peak atrial flow velocity; DcT — deceleration time; S — pulmonary 
vein systolic velocity; D — pulmonary vein diastolic velocity; Arev — pulmonary vein atrial reversal flow velocity; E’ — peak early diastolic 
velocity of mitral annulus
Table 4. Morphological parameters of the left atrium before and 6 months after bariatric surgery (BS) 
(n = 60).
Parameter Before BS After BS P
LAd [mm] 36.0 (28.0–40.0) 34.5 (25.0–40.0) 0.003*
LAa [cm2] 17.3 ± 2.6 16.2 ± 2.4 < 0.001**
LAV [mL] 45.0 (25.0–94.0) 39.0 (21.0–76.0) < 0.001*
LAVI [mL/m2] 21.3 ± 5.3 21.4 ± 5.3 0.636**
*Wilcoxon signed-rank test; **Student’s t-test. Data are expressed as mean ± standard deviation or median and range; LAd — left atrial diameter; 
LAa — left atrial area; LAV — left atrial volume; LAVI — left atrial volume index
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Body mass and echocardiography parameters 
An analysis of echocardiographic parameters 
showed the following significant correlations: BM 
prior to surgery correlated significantly with the 
PW thickness (r = 0.30, p = 0.021), LVM (r = 0.31, 
p = 0.016), and LAV (r = 0.26, p = 0.048). Moreo-
ver, a statistical trend for the correlation between 
the IVS thickness and BM was observed (r = 0.23, 
p = 0.080).
The changes in BM (Dbody mass) were signi-
ficantly correlated with the changes in PW thick-
ness (r = 0.32, p = 0.013) and with LVM reduction 
(r = 0.27, p = 0.034). A marginally significant effect 
was shown for changes in IVS thickness (r = 0.25, 
p = 0.058).
No significant correlations were observed 
between BP values and echo-parameters obtained 
during the first examination. 
Discussion
Obesity is a recognized factor of increased 
cardiovascular morbidity and mortality [14]. It 
leads to unfavorable remodeling of LV including its 
hypertrophy and LV dysfunction in a high fraction 
of obese people [15, 16]. The analysis of approxi-
mately 1160 severely obese patients performed by 
Avelar et al. [17] showed that increasing systolic 
BP and increasing BMI were independently associ-
ated with increased LVMI.
This study found moderate LVH, defined as 
LVM between 187 g and 210 g, in approximately 
one third of the obese, but none of the subjects 
studied herein suffered from severe LVH. Only 
patients with well-controlled hypertension, no evi-
dent HF or CAD, were included in the study, which 
may explain why relatively mild LV remodeling 
was observed. However, the indexation of LVM 
to height raised to the power of 2.7 identified in 
the study group more patients with LVH than the 
indexation to BSA. 
Of note, significant correlations were found be-
tween the initial BM and LV wall thickness as well 
as LVM. Interestingly, we found no relationship 
between hypertension and the echocardiographic 
parameters. This indicates that obesity in itself is 
a driving factor of LVH. Moreover, the postopera-
tive BM decrease correlated with the degree of 
LVM reduction.
Some authors reported echocardiographic 
signs of LVDD and increased LVFP in obese pa-
tients who were hypertensive and older than the 
remaining participants of the studied groups [7].
Despite advanced class III obesity according 
to the WHO, prior to bariatric surgery, we found 
LVDD of grade I (impaired myocardial relaxation) 
based on mitral and pulmonary inflow and TDI 
criteria only in 3 patients who also had hyperten-
sion and were older than the rest of the studied 
patients. After BS, 2 of them still met the prede-
fined criteria for LVDD. None of studied patients 
met the criteria of increased LV filling pressure (no 
cases with an average E/E’ > 13) before and after 
surgery. As mentioned above, this finding can be 
potentially explained by the selection criteria used 
in our study. It is known, that patient age should 
be taken into account when LVDF parameters 
are analyzed. The observed group was relatively 
young, with mean age of 37.1 years. However, 
significant postoperative improvement in a wide 
range of Doppler indices of LVDF were observed. 
A significant increase in E/A ratio in MVI and of 
diastolic velocity (D) of PVI with a decreased S/D 
ratio was noted. Moreover, the higher E’lat values 
observed after surgery reflected an improvement in 
movement for this part of the mitral annulus. Con-
sequently, the lateral E/E’ ratio was significantly 
lower than that obtained upon first examination. 
These results are in line with observations sug-
gesting that weight loss following bariatric surgery 
improves LVDF. Fenk et al. [7] reported results 
after a 1-year follow-up in obese patients with 
LVDD, who achieved successful WL and significant 
improvement in E/A, E’ or E/E’.
It is possible that changes in LVDF in the 
studied women may depend not only on  decreased 
LVM and improved myocardial properties but also 
decreased content of epicardial fat tissue, which 
due to mechanical impairment of ventricle filling 
which may have had an impact on LVDF [18].
Left atrium enlargement reflects a chronic ex-
posure to increased LVFP and is a well-recognized 
marker of long-lasting LVDD [12]. Prior to surgery, 
LA enlargement, defined as the presence of at least 
one abnormal LA echo-parameter (LAd, LAa, LAV), 
was observed in approximately 16% of patients. 
All of these parameters were significantly lower 
postoperatively. Interestingly, the reduction in 
the LA size was not significant in severely obese 
patients with LVDD, as reported by Fenk et al. [7] 
1 year after BS.
It is of importance in the presented group of 
patients was that the indexed parameters such 
as LAVI may sometimes not show any change in 
volume because both LAV and BSA decrease simul-
taneously [19]. In the present observation before 
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surgery, LAVI did not exceed the recommended 
upper range in all patients with LA enlargement 
due to higher values of BSA, this was only revealed 
in postoperative assessment (BSA decreased, 
whereas LAV was comparable).
As already established, LA enlargement is 
associated with the risk of developing atrial fibril-
lation [20]. 
It is assumed that normalization of LA dimen-
sions reflects a favorable impact of BS not only on 
LVDF but also on LA morphology and may lower 
the risk of supraventricular arrhythmias in obese 
patients [19]. 
Limitations of this study
This is a single center study comprised of 
a relatively small group of patients.  Moreover, the 
studied group was rather homogenous. All women 
included in the study were diagnosed with class 
III obesity (BMI ≥ 40 kg/m2) and nearly the entire 
group benefited from a large reduction in BM. Since 
only relatively young women without significant 
cardiovascular complications were studied, it is 
difficult to extrapolate our results to the gen-
eral population of obese people. In severely obese 
patients, echocardiographic measurements are 
especially susceptible to errors due to suboptimal 
visualization of cardiac structures which can also 
limit the power of observed correlations.
Conclusions
Weight loss 6 months subsequent to bariatric 
surgery resulted in improvement of left ventricu-
lar diastolic function and left heart morphology in 
morbidly obese women.
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